
New estrogen receptor antagonists. 3,20-Dihydroxy-19-norpregna-1,3,5(10)-trienes: Synthesis, molecular modeling, and biological evaluation
Keywords: Antiestrogens; Estrogen receptor α; Cytotoxicity; 19-Norpregnatriene; Cycloaddition; NMR assignment; Breast cancer;